European Commission Publishes Landmark Guidelines on Exclusionary Abuses by Dominant Companies
What You Need to Know
Key takeaway #1
The Guidelines represent the most significant reset of the European Commission’s Article 102 framework in almost 20 years, with comprehensive principles for assessing dominance and exclusionary abuses.
Key takeaway #2
Dominance is generally unlikely where a company’s market share remains below 40%, although a finding of dominance at lower thresholds is not excluded— with particular attention to digital and platform markets.
Key takeaway #3
The Guidelines establish conduct-specific analytical frameworks — from predatory pricing and margin squeeze to self-preferencing and "by its very nature harmful" conduct —, and certain practices (such as exclusive dealing) carry a presumption of harm with the burden shifting to the dominant firm.
Client Alert | 4 min read | 09.10.26
On 3 September 2026, the European Commission adopted new Guidelines on the application of Article 102 TFEU to abusive exclusionary conduct by dominant undertakings. The Guidelines follow a public consultation on a draft published in August 2024 and reflect substantial stakeholder feedback. They replace the Commission's 2008 Guidance on enforcement priorities (which ceases to apply 30 days after publication of the new guidelines in the Official Journal) and represent the most significant reset of the Commission's Article 102 enforcement framework in nearly two decades. The Commission's stated aim is to set out principles and operational guidance, enhance legal certainty, and help companies self-assess their exclusionary-abuse risk.
In this alert, we give you an overview of the Guidelines’ key elements and provide a list of urgent action points for in-house counsel at companies with a significant market position in the EU. In-house counsel should consider these Guidelines as a compliance trigger.
Key Points
How is Dominance Assessed?
A sustained market share of approximately 50% or more is, save in exceptional circumstances, in itself evidence of dominance. In a notable addition to the 2024 draft, the final Guidelines reconfirm a soft safe harbor: dominance is generally unlikely if the market share is below 40%, though it remains a possibility, depending on other factors.
Beyond market share, the Guidelines place particular emphasis on data-driven advantages, network effects, "winner-takes-all" dynamics, lock-in and switching costs, and digital ecosystem features as factors that can raise entry barriers and entrench dominance. Companies in digital and platform markets may face a dominance finding at lower share thresholds than in traditional markets. For after-markets (accessories, maintenance, software), the Commission will examine whether competition in the primary market disciplines after-market conduct.
Is it Abusive Exclusionary Conduct?
The Commission bases its assessment on a "theory of harm" — that is, how conduct can harm consumers via market structure — and relies on a two-pronged analytical framework: (1) is there a departure from competition on the merits and (2) is the conduct capable of having exclusionary effects.
Importantly, the Guidelines confirm there is no legal requirement to demonstrate direct harm to consumers to establish a distortion of effective competition. Exclusionary effects need only be more concrete than purely hypothetical. Actual effects need not be proven, and there is no de minimis threshold under Article 102 TFEU.
On the "equally efficient competitor" (AEC) test: For pricing conduct (predatory pricing, margin squeeze, conditional rebates), the assessment typically centers on whether the conduct can exclude a hypothetical equally efficient competitor, usually via price-cost tests using the dominant undertaking's own contemporaneous data. For non-pricing conduct and digital ecosystems, AEC quantification may not be meaningful, and qualitative evidence and market developments carry more weight.
Conduct-Specific Frameworks
The Guidelines set out specific analytical frameworks for the following types of conduct.
Objective Justifications
Conduct that distorts competition may still be justified if (1) there is objective necessity or (2) there are efficiencies that counterbalance or outweigh the harm. The burden of proof lies with the dominant undertaking. Justifications require convincing evidence; vague or theoretical claims, or claims based exclusively on commercial interest, are insufficient. Compared to the 2024 draft, the final Guidelines significantly expand the guidance on objective justifications, providing more detailed direction on the types of evidence the Commission will assess and the evidentiary standard such evidence must meet, including by recognizing sustainability benefits as a distinct form of efficiency defense.
Efficiencies must be objective, concrete, and verifiable, supported where possible by contemporaneous internal documents and financial materials. Specifically, four cumulative conditions must be met: (a) efficiencies must be achieved, (b) they must counteract negative effects on competition and consumers, (c) the conduct must be necessary, and (d) effective competition must not be eliminated.
Overlap with the Digital Markets Act and Other Regimes
The Guidelines are without prejudice to other EU and national regulatory regimes. Article 102 TFEU can apply even where conduct is subject to sector-specific regulation, and conduct may be sanctioned under Article 102 regardless of whether it complies with or falls outside other legal frameworks.
For example, compliance with the Digital Markets Act or sector-specific rules will not protect an undertaking from Article 102 scrutiny. Therefore, a parallel Article 102 assessment for all commercially significant practices involving dominant market positions is required.
Key Action Points for In-House Counsel
1. Update your compliance frameworks. Internal compliance programs, dominance assessments, and commercial practice reviews should be refreshed taking the new Guidelines into account. Dominance assessments should not just include market share data but also an analysis of data access, user lock-in, ecosystem linkages, and switching costs.
2. The evidentiary route depends on the type of conduct — know which applies to you. You should map your current commercial practices. Pricing practices (predatory pricing, margin squeeze, rebates) are typically assessed via AEC/price-cost tests using internal data. Ensure finance teams can generate AEC/price-cost-test-ready data using internal accounting records. Non-pricing practices and digital market conduct are assessed through broader qualitative theories of harm. Build a documented qualitative effects narrative alongside any quantitative analysis.
3. Presumptions and burden-shifting are real risks — build rebuttal evidence early. For exclusive dealing, a presumption of harm applies once exclusivity is established, shifting the burden to the dominant firm. For objective justifications, the burden of proof lies entirely with the dominant undertaking and requires convincing, contemporaneous evidence. Build a contemporaneous "objective justification pack" covering: technical integrity or security rationale; consumer benefit analysis; less-restrictive-alternatives assessment; and evidence of consumer pass-on where relevant. You should build your file now, not during an investigation.
Contacts
Insights
Client Alert | 8 min read | 09.08.26
Saxon Woods Investments Limited v Costa [2026] UKSC 21: Good Faith in the Boardroom
The UK Supreme Court has unanimously dismissed the appeal of Mr Francesco Costa, former chairman of Spring Media Investments Limited, in the first Supreme Court judgment to consider the scope of the duty under section 172(1) of the Companies Act 2006. The foundational position is that good faith requires honest conduct as well as honest thinking. A director's genuine belief that they are acting in the company's best interests will not excuse covert or disloyal conduct in pursuit of that belief.
Client Alert | 2 min read | 09.08.26
IRS Takes Aim: Proposed Rule Threatens Tax-Exempt Status of Private Schools
Client Alert | 5 min read | 09.03.26
Client Alert | 6 min read | 09.03.26
FDA Seeks Input for Regulating GenAI-Powered Medical Devices


